Zanetti I. R., Mouse Models of Renal Allograft Transplant Rejection: Methods to Investigate Chemokine–GAG Interaction and Therapeutic Blockade 2023
Chen P., Mouse Corneal Transplantation 2023
Guo Q., Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models 2021
Zhang L., Topical Application of Virus-Derived Immunomodulating Proteins and Peptides to Promote Wound Healing in Mouse Models 2021
Lucas A., Overview of serpins and their roles in biological systems 2018
Maldonado J., Next-generation sequencing library preparation for 16S rRNA microbiome analysis after serpin treatment 2018
Ambadapadi S., Serpins, viruses, and the virome: New directions in therapy [Book Chapter] 2015
Chen H., Viral serpin therapeutics: From concept to clinic 2011
Rahman M. M., Viral TNF inhibitors as potential therapeutics 2009
Lucas A., The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics 2009
Bartee M. Y., Chapter 10 M-T7. Measuring Chemokine-Modulating Activity 2009
Canham P. B., Collagen organization and biomechanics of the arteries and aneurysms of the human brain [Book Chapter] 2006
Nash P., Serp-1, a poxvirus-encoded serpin, is expressed as a secreted glycoprotein that inhibits the inflammatory response to myxoma virus infection 1997
Publications
Journal for immunotherapy of cancer Li Xuemei, FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription 12:7, p. e009565 2024
Nature communications Dodd-O Joseph, Author Correction: Antiviral fibrils of self-assembled peptides with tunable compositions 15:1, p. 1505 - 1505 2024
Biomolecules (Basel, Switzerland) Varkoly Kyle, Viral SERPINS—A Family of Highly Potent Immune-Modulating Therapeutic Proteins 13:9, p. 1393 2023
EMBO molecular medicine Zhang Liqiang, Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV ‐2 mouse models of infection, p. e17376 - e17376 2023
EMBO Molecular Medicine C Bouton M., The under-appreciated world of the serpin family of serine proteinase inhibitors 15:6 2023
Digestive diseases and sciences Feng Y., Retraction Note to: A Novel Method for the Prevention and Treatment of Small‑for‑Size Syndrome in Liver Transplantation(Digestive Diseases and Sciences, (2020), 65, (2619–2629), 10.1007/s10620-020-06055-2) 68:1 2023
Methods in molecular biology (Clifton, N.J.) Zanetti Isabela R, Mouse Models of Renal Allograft Transplant Rejection: Methods to Investigate Chemokine-GAG Interaction and Therapeutic Blockade 2597 2022
Pathogens Zanetti I. R., Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine–Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage 11:5 2022
Cancers Christie J. D., Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma 14:2 2022
Current Neuropharmacology Kwiecien J. M., The role of astrogliosis in formation of the syrinx in spinal cord injury 19:2 2021
Frontiers in Public Health Fath A. R., Chronological Impact of Earthquakes on Blood Pressure: A Literature Review and Retrospective Study of Hypertension in Haiti Before and After the 2010 Earthquake 8 2021
Biomedicines Kwiecien J. M., Neuroprotective effect of subdural infusion of serp-1 in spinal cord trauma 8:10 2020
Pharmaceutics Yaron J. R., Recombinant myxoma virus‐derived immune modulator m‐t7 accelerates cutaneous wound healing and improves tissue remodeling 12:11 2020
Journal of Clinical Medicine Yaron J. R., Deriving immune modulating drugs from viruses— AA new class of biologics 9:4 2020
Trends in molecular medicine Yaron J. R., Modifying the Organ Matrix Pre-engraftment: A New Transplant Paradigm? 25:7 2019
Folia Neuropathologica Kwiecien J. M., Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model 57:1 2019
Biochemistry Mahon B. P., Crystal Structure of Cleaved Serp-1, a Myxomavirus-Derived Immune Modulating Serpin: Structural Design of Serpin Reactive Center Loop Peptides with Improved Therapeutic Function 57:7 2018
Cardiovascular and Hematological Disorders - Drug Targets Al-Ani M., Atrial fibrillation ablation increases inflammation-chemokine modulation suppresses activation of leukocytes isolated after ablation 17:3 2017
PLoS ONE Kwiecien J. M., Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis 12:9 2017
Infection and immunity Velsko I. M., Periodontal pathogens invade gingiva and aortic adventitia and elicit inflammasome activation in αvβ6 integrin-deficient mice 83:12 2015
Pathogens and Disease Chukkapalli S. S., Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers 73:3 2015
PLoS ONE Velsko I. M., Fusobacterium nucleatum alters atherosclerosis risk factors and enhances inflammatory markers with an atheroprotective immune response in ApoEnull mice 10:6 2015
Journal of Clinical and Experimental Cardiology Lucas A., The virome: Viral ghost companion, virus wars 5:8 2014
Journal of Clinical and Experimental Cardiology Lucas A., Women in cardiology: The x factor and the heart of medicine 5:2 2014
European Journal of Inflammation Davids J. A., Viral anti-inflammatory proteins target diverging immune pathways with converging effects on arterial dilatation, plaque and apoptosis 12:1 2014
PLoS ONE Lucas A. R., Myxomavirus anti-inflammatory chemokine binding protein reduces the increased plaque growth induced by chronic porphyromonas gingivalis oral infection after balloon angioplasty aortic injury in mice 9:10 2014
Cardiovascular and Hematological Disorders - Drug Targets Chen H., The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation 13:2 2013
Journal of Cancer Science and Therapy Zheng D., Myxomaviral anti-inflammatory serpin reduces myeloid-derived suppressor cells and human pancreatic cancer cell growth in mice 5:8 2013
Cardiovascular and Hematological Disorders - Drug Targets Zheng D., Serpins for diagnosis and therapy in cancer 13:2 2013
Cardiovascular and Hematological Disorders - Drug Targets Lucas A., Serpins as therapeutics - A potential biologic source for unique protein-based therapeutics 13:2 2013
Antimicrobial Agents and Chemotherapy Chen H., Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection 57:9 2013
PLoS ONE Rivera M. F., Polymicrobial Infection with Major Periodontal Pathogens Induced Periodontal Disease and Aortic Atherosclerosis in Hyperlipidemic ApoEnull Mice 8:2 2013
Trends in molecular medicine Zheng D., Virus-derived anti-inflammatory proteins: Potential therapeutics for cancer 18:6 2012
Current Drug Delivery Kennedy K. L., Local delivery of therapeutics for percutaneous coronary intervention 8:5 2011
Infection and immunity Nahid M. A., Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/- mice during experimental periodontal disease 79:4 2011
Photochemistry and photobiology Korol R. M., Detection of altered extracellular matrix in surface layers of unstable carotid plaque: An optical spectroscopy, birefringence and microarray genetic analysis 87:5 2011
Circulation: Cardiovascular Interventions Lucas Alexandra, A randomized controlled, phase 2 trial of the viral serpin serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention 3:6 2010
Thrombosis and haemostasis Munuswamy-Ramanujam G., Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets 103:3 2010
Journal of leukocyte biology Viswanathan K., Myxoma viral serpin, serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B 85:3 2009
Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Davids J. A., Viral anti-inflammatory proteins: The potential for immunotherapeutic applications in cancer 7:2 2008
Journal of Biomedical Optics Korol R. M., Fluorescence spectroscopy and birefringence of molecular changes in maturing rat tail tendon 12:2 2007
Cardiovascular Pathology Richardson M., Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model 16:4 2007
Transplantation Jiang J., Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment 84:9 2007
Endocrine, Metabolic and Immune Disorders - Drug Targets Munuswamy-Ramanujam G., Viral anti-inflammatory reagents: The potential for treatment of arthritic and vasculitic disorders 6:4 2006
Frontiers in Bioscience Richardson J., Serpins, the vasculature, and viral therapeutics 11:1 P.889-1198 2006
Journal of Biological Chemistry Dai E., Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses 281:12 2006
Circulation Lucas A. R., Inflammation in atherosclerosis: Some thoughts about acute coronary syndromes 113:17 2006
Transplantation Bédard E. L. R., Prevention of chronic renal allograft rejection by SERP-1 protein 81:6 2006
Current Drug Targets - Cardiovascular and Haematological Disorders Lucas A., Editorial 5:1 2005
Photochemistry and photobiology Christo A., In vivo optical analysis of quantitative changes in collagen and elastin during arterial remodeling 81:2 2005
Virology Cameron C. M., Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo 337:1 2005
Journal of Immunology Lucas A., Secreted immunomodulatory viral proteins as novel biotherapeutics 173:8 2004
Transplantation Liu L., Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models 77:11 2004
Current Drug Targets - Cardiovascular and Haematological Disorders Lucas A., Preface 2:1 2002
Lucas A., Circulating blood cells trigger acute inflammatory responses in the artery wall 2002
Christov A., Fluorescence spectroscopic analysis (FSA) detects quantitative changes in atherosclerotic plaque collagen and elastin content in vivo 2002
Current drug targets.Cardiovascular & haematological disorders Bocksch L., Apolipoprotein E: possible therapeutic target for atherosclerosis. 1:2 2001
Lasers in surgery and medicine Christov A., Fluorescence spectroscopic analysis of circulating platelet activation during coronary angioplasty 28:5 2001
Journal of the American College of Cardiology Zalai C. V., Increased circulating monocyte activation in patients with unstable coronary syndromes 38:5 2001
Photochemistry and photobiology Christov A., Optical detection of triggered atherosclerotic plaque disruption by fluorescence emission analysis 72:2 2000
Proceedings of SPIE - The International Society for Optical Engineering Christov A., Laser-induced Fluorescence Spectroscopy (LFS): Detection of unstable thrombogenic atherosclerotic plaque formation in a rabbit model - A first look diagnostic approach 4161 2000
Radiology Clarke S. E., Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits 214:3 2000
Journal of Clinical Investigation Liu L., The vital anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury 105:11 2000
Christov A., A three tiered fluorescence-based system for monitoring activation-related changes in human platelets 2000
Metabolism: Clinical and Experimental Hatton M. W. C., Metabolism and distribution of the virus-encoded serine proteinase inhibitor SERP-1 in healthy rabbits 49:11 2000
Journal of Heart and Lung Transplantation Lucas A., Transplant vasculopathy: Viral anti-inflammatory serpin regulation of atherogenesis 19:11 2000
Circulation Miller L. W., Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin 101:13 2000
Photochemistry and photobiology Christov A. M., Laser-induced fluorescence (LIF) recognition of the structural composition of porcine heart valves 69:3 1999
Lasers in surgery and medicine Christov A., Detection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysis 24:5 1999
Virology Lalani A. S., Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M- T1, during myxoma virus pathogenesis 256:2 1999
Virology Hnatiuk S., Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis 263:2 1999
Virology Graham K. A., The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues 229:1 1997
Arteriosclerosis, Thrombosis, and Vascular Biology Dai E., Calreticulin, a potential vascular regulatory protein, reduces intimal hyperplasia after arterial injury 17:11 1997
Lasers in surgery and medicine Bauer J., Comparative study of Nd:YAG laser angioplasty at 1.06 μm, 1.32 μm, and 1.44 μm wavelengths: Decreased vascular spasm and early mortality with 1.44 μm laser ablation 19:3 1996
Atherosclerosis Lucas A., Development of an avian model for restenosis 119:1 1996
Circulation Lucas A., Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty 94:11 1996
Virology Mossman K., Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits 215:1 1996
Pacing and Clinical Electrophysiology PERK M., Laser Induced Fluorescence Identification of Sinoatrial and Atrioventricular Nodal Conduction Tissue 16:8 1993
American Heart Journal Lucas A. R., Angiographic contrast media interference with laser-induced fluorescence excitation and detection in atherosclerotic human coronary arteries 121:1 PART 1 1991
American Heart Journal Gal D., Atherosclerotic Yucatan microswine: An animalmodel with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions 119:2 PART 1 1990
Lasers in surgery and medicine Gaffney E. J., Correlation of fluorescence emission with the plaque content and intimal thickness of atherosclerotic coronary arteries 9:3 1989
The American Journal of Cardiology Desnoyers M. R., Clinical and noninvasive hemodynamic results after aortic balloon valvuloplasty for aortic stenosis 62:16 1988
Virology Lucas A., In vivo and in vitro models of demyelinating diseases II. Persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses 88:2 1978
Cell Lucas A., In vivo and in vitro models of demyelinating diseases: Tropism of the JHM strain of murine hepatitis virus for cells of glial origin 12:2 1977